|
|
Enron Mail |
In today's edition of the Daily Update, e-procurement, just-in-time
strategies, and old economy verticals integrating New Economy technologies, from Prudential Financial, Bear Stearns, Stephens Inc., Argus Research, and Dain Rauscher Wessels. Also, Morgan Stanley rates Genzyme General (GENZ) a "strong buy." Click here for research: http://www.multexinvestor.com/article.asp?docid=3657&;nd=1025 *************************************************************** You are receiving this mail because you have registered for Multex Investor. To unsubscribe, see bottom of this message. *************************************************************** ======================== Sponsored by ========================= Baby Boomers Go Bust! Long before terror struck, Baby Boomers were in big trouble. Big houses, big SUVs, big mortgages. And No Savings! Now war and recession. Protect yourself. Click here to learn how: http://www.agora-inc.com/reports/STRT/BulidYourFuture =============================================================== Featured in today's edition of the Daily Update: 1. SPECIAL REPORT: Bear Stearns reports on the impact of e-procurement on industrial companies. 2. EDITOR'S PICK: Stephens Inc. analyzes the impact of Internet adoption on select industry verticals. 3. ASK THE ANALYST: Market Edge's Tom Ventresca explains how to find winning stocks using cyclical analysis. 4. ASK THE EXPERT: American Century's Jim Lauterwasser discusses 401(k) plan options when changing jobs or retiring. 5. HOT REPORT: Dain Rauscher Wessels reviews three collaborative commerce software stocks. 6. DAILY FREE SPONSOR REPORT: Morgan Stanley sets a $72 price target for diagnostic company Genzyme General (GENZ). 7. THIRD-PARTY REVIEW: Argus Research argues that utilities are "currently a very attractive place for investors." 8. INVESTORS' CHOICE: 3-DAY FAVORITE: Robertson Stephens expects biotechnology stocks to have strong earnings this quarter and onwards. 9. LIVE EVENT: Learn what your options are for your retirement plan money when you change jobs or retire. 10. FREE RESEARCH REPORT: Prudential compares two indexes and two competing investment philosophies. 11. INVESTMENT IDEAS: The other shoe never dropped, and now the stock price looks as beguiling as a brand new pair of pumps. 12. INVESTMENT IDEAS: Investors ignore the pundits. 13. INVESTMENTOR: You may grow comfortable with your spouse, but you might want to lose stocks that wear curlers to bed. ======================== Sponsored by ========================= Paying too much for AUTO Insurance? Take a test drive on Insurance.com - where some of America's Best Known Carriers compete to help you SAVE. Get no-obligation QUOTES. COMPARE with your own policy. Don't pay more than you have to. Seek the best policy for your money - Insurance.com http://ad.doubleclick.net/clk;3267859;5840728;z?http://www.insurance.com/entry.asp?sid=3787 =============================================================== 1. TODAY'S SPECIAL REPORT Bear Stearns reports on the impact of e-procurement on industrial companies. The firm notes that companies using Internet-enabled procurement are better positioned to achieve sustainable advantages under certain conditions. The report contains two "buy" recommendations among major industrials. (66-page report for purchase - $150) Click here. http://www.multexinvestor.com/download.asp?docid=25157607&;nd=1025 2. EDITOR'S PICK: CURRENT RESEARCH FROM THE CUTTING EDGE Stephens Inc. analyzes the impact of Internet adoption on select industry verticals. The firm notes accelerated adoption of Web-based technologies in healthcare as part of an effort to streamline financial processes, investigates stocks in five industry verticals, and initiates coverage of three Web stocks. (84-page report for purchase - $150) Click here. http://www.multexinvestor.com/download.asp?docid=25149993&;nd=1025 3. ASK THE ANALYST Market Edge's Tom Ventresca explains how to find winning stocks using cyclical analysis. Ventresca believes that investors can narrow down profitable equity selections by analyzing recent stock cycles. How does this strategy work and should you be using it? Ventresca can take your questions only today, Thurs., Oct. 25. Ask the analyst. Click here. http://www.multexinvestor.com/AskTheAnalystForm.asp?&;nd=1025 Register to receive a FREE weekly market commentary and get Market Edge for 14 days FREE! Get unbiased, computer generated BUY-HOLD-SELL opinions on 5,000 stocks and more. Click here http://www.marketedge.com/multex.asp?Location=3. 4. ASK THE EXPERT American Century's Jim Lauterwasser discusses 401(k) plan options when changing jobs or retiring. Lauterwasser explains that investors must be careful when moving money from a 401(k) plan in order to avoid IRS penalties. What are your choices when it comes to transferring these monies? Pose him questions until Thurs. Nov. 1. Ask the expert. Click here. http://www.multexinvestor.com/AskTheExpertForm.asp?&;nd=1025 5. WHAT'S HOT? Dain Rauscher Wessels reviews three collaborative commerce software stocks. The firm urges investors to take "a more constructive view" of the Web-based B2B sector and reviews i2 Technologies (ITWO), Retek (RETK), and SAP (SAP), which have "rebounded nicely" despite poor business fundamentals. (2-page report for purchase - $10) Click here. http://www.multexinvestor.com/download.asp?docid=25189629&;nd=1025 ======================== Sponsored by ========================= The Internet Analyst: Wall Street's daily and weekly industry outlook Multex's The Internet Analyst features daily 'Net-industry specific research highlights, investment ideas, analyst opinions, portfolio strategies: http://www.multexinvestor.com/Analysts/HomeTIA.asp To be sure you receive your TIA newsletter every week, click here: http://www.multexinvestor.com/login.asp =============================================================== 6. DAILY FREE SPONSOR REPORT Morgan Stanley sets a $72 price target for diagnostic company Genzyme General (GENZ). The firm upgrades GENZ from "outperform" to "buy" as uncertainty over an FDA approval has been lifted, arguing that shares will now benefit from "increasingly positive" fundamentals. Register for the firm's free-research trial to access research on this "strong buy " rated stock. Click here. http://www.multexinvestor.com/download.asp?docid=4522382&;sid=8&nd=1025 7. THIRD-PARTY REVIEW Argus Research argues that utilities are "currently a very attractive place for investors." The firm notes that investors should benefit from solid dividend yields, fairly inelastic demand, and continued strong fundamentals, discusses three "buy"-rated stocks in detail, and lists more than 100 utility stocks. (4-page report for purchase - $40) Click here. http://www.multexinvestor.com/download.asp?docid=25180561&;nd=1025 8. INVESTORS' CHOICE: 3-DAY FAVORITE Robertson Stephens expects biotechnology stocks to have strong earnings this quarter and onwards. The firm anticipates a few shortfalls mixed in with largely positive news on the earnings front, including a few upside surprises, and reviews over 20 stocks, including six "strong buy" and 12 "buy" recommendations. (7-page report for purchase - $25) Click here. http://www.multexinvestor.com/download.asp?docid=25116634&;nd=1025 9. LIVE EVENT Learn what your options are for your retirement plan money when you change jobs or retire. TONIGHT at 8pm ET, American Century Investment's Jim Lauterwasser will answer questions on what your options are with your retirement plan money when you change jobs or retire. Don't miss this chance to learn more. Click here. http://oem.sageonline.com/chat/chat.asp?forumid=139&;nd=1025 10. FREE RESEARCH REPORT Prudential compares two indexes and two competing investment philosophies. The firm shows evidence which it says proves the supremacy of the Russell index over the S&P over the past year. The firm also urges investors to tilt portfolios towards growth stocks. This report is free for a limited time. Click here. http://www.multexinvestor.com/download.asp?docid=25177260&;nd=1025 11. INVESTMENT IDEAS The other shoe never dropped, and now the stock price looks as beguiling as a brand new pair of pumps. Multex.com director of investment research Marc Gerstein notes that the eponymous shoe retailer didn't miss a beat when its namesake founder got tangled up in legal trouble, has a deep and strong management team, and continues to be as popular with its demographic as a pop star. Click here. http://www.multexinvestor.com/article.asp?docid=3615&;nd=1025 12. INVESTMENT IDEAS Investors ignore the pundits. Equity research columnist Dave Sterman says that while some telecom stocks received continued analyst support, investors that read between the lines can see signs of trouble for this much-beleaguered sector. Sterman reports on the prospects for three stocks on the short list. Click here. http://www.multexinvestor.com/article.asp?docid=3650&;nd=1025 13. THE INVESTMENTOR You may grow comfortable with your spouse, but you might want to lose stocks that wear curlers to bed. Columnist William Valentine suggests that it is now time to dump defensive stocks that have stood investors in good stead during difficult market conditions in favor of more growth-oriented issues. Click here. http://www.multexinvestor.com/article.asp?docid=3653&;nd=1025 =================================================================== Please send your questions and comments to: mailto:investor.help@multex.com If you'd like to learn more about Multex Investor, please visit: http://www.multexinvestor.com/welcome.asp If you can't remember your password and/or your user name, click here: http://www.multexinvestor.com/lostinfo.asp If you want to update your email address, please click on the url below: http://www.multexinvestor.com/edituinfo.asp =================================================================== To remove yourself from the mailing list for the Daily Update, please REPLY to THIS email message with the word UNSUBSCRIBE in the subject line. To remove yourself from all Multex Investor mailings, including the Daily Update and The Internet Analyst, please respond with the words NO EMAIL in the subject line. You may also unsubscribe on the account update page at: http://www.multexinvestor.com/edituinfo.asp =================================================================== Please email advertising inquiries to us at: mailto:advertise@multex.com. Be sure to check out our other newsletters, The Internet Analyst and The Telecomm Analyst by Multex.com. The newsletters will inform, educate, and entertain you with usable investment data, ideas, experts, and info about the Internet and telecommunications sectors. To see this week's issue, click here: http://www.thetelecommanalyst.com/ or http://www.theinternetanalyst.com/
|